Soc. Generale Knock-Out BIO/ DE000SU1EA08 /
11/19/2024 2:19:13 PM | Chg.-0.400 | Bid2:20:54 PM | Ask2:20:54 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
9.810EUR | -3.92% | 9.800 Bid Size: 2,000 |
10.390 Ask Size: 2,000 |
Bio Rad Laboratories... | 203.5418 USD | 12/31/2078 | Call |
GlobeNewswire
8/12
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
6/24
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
6/3
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
3/29/2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
3/22/2022
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
8/3/2021
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
6/1/2021
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
8/24/2020
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
5/4/2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
4/16/2020
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
3/20/2020
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors